Finance

Lists
NVRS:CNSX
Noveris Health Sciences Inc
0,065 CAD
0,00%
(0,00) 1D
16-окт., 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NVRS...
Open
0,07 CAD
High
0,07 CAD
Low
0,06 CAD
Mkt. cap
3,53 млн
Avg. vol.
431,61 миң
Volume
473,34 миң
P/E ratio
0,03
52-wk high
3,00 CAD
52-wk low
0,06 CAD
EPS
2,52 CAD
No. of employees
3
Open
0,07 CAD
High
0,07 CAD
Low
0,06 CAD
Mkt. cap
3,53 млн
Avg. vol.
431,61 миң
Volume
473,34 миң
P/E ratio
0,03
52-wk high
3,00 CAD
52-wk low
0,06 CAD
EPS
2,52 CAD
No. of employees
3
News stories
From web sources and news partners
About Noveris Health Sciences Inc
CEO-
Employees3
Founded2013
HeadquartersВанкувер, Бритиш Колумбия, Канада
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-40,14 миң
-
-
32,79 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-70,57 миң
5,04 миң
316,29 миң
669,62 миң
Operating expense
-110,70 миң
5,04 миң
316,29 миң
702,42 миң
Total operating expenses
-110,70 миң
5,04 миң
316,29 миң
702,42 миң
Operating income
110,70 миң
-5,04 миң
-316,29 миң
-702,42 миң
Other non operating income
85,53 миң
-417,63 миң
-1,32 млн
640,56 миң
EBT including unusual items
73,79 миң
3,16 млн
-1,62 млн
22,81 миң
EBT excluding unusual items
73,79 миң
-405,27 миң
-1,62 млн
-155,29 миң
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
73,79 миң
3,16 млн
-1,62 млн
22,81 миң
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-26,16 миң
-12,63 миң
-9,90 миң
Net interest expenses
-
-26,16 миң
-12,63 миң
-9,90 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору